NRG4 expression is reduced in adipose tissue from obese mice, and lower plasma NRG4 levels are associated with obesity, insulin resistance, and NAFLD in humans (22–24). This evidence concerns the gene NRG4 and metabolic dysfunction-associated steatotic liver disease.